• One example is a human study in which researchers discovered that higher levels of the antioxidant selenium in the blood of patients with aggressive B-cell non-Hodgkin's lymphoma correlated with increased achievable doses of anthracycline based chemotherapy, better treatment response, achievement of long term remission, and longer overall survival. (pinestreetfoundation.org)
  • We assessed the feasibility of using chemical gustometry (CG) to measure dysgeusia and explored its associations with symptom burden, nutrition, chemotherapy pharmacokinetics (PK), and the oral microbiome. (bvsalud.org)
  • Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer. (shengsci.com)
  • abstract: PURPOSE:We conducted a phase II trial to evaluate the efficacy and safety of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for advanced non-squamous non-small-cell lung cancer (NSCLC). (shengsci.com)
  • The first dose of Neupogen should be administered at least 24 hours after cytotoxic chemotherapy. (medicines.org.uk)
  • Following induction and consolidation treatment for acute myeloid leukaemia the duration of treatment may be substantially longer (up to 38 days) depending on the type, dose and schedule of cytotoxic chemotherapy used. (medicines.org.uk)
  • A randomized trial compared prednisone plus intravenous melphalan to prednisone plus oral melphalan in the treatment of myeloma. (nih.gov)
  • Both arms received oral prednisone starting at 0.8 mg/kg/day with doses tapered over 6 weeks. (nih.gov)
  • Newly diagnosed multiple myeloma in patients who are ineligible for autologous stem cell transplant (in combination with bortezomib, melphalan, and prednisone). (drugguide.com)
  • Up to date over the counter equivalent to revlimid of the FIRST study: steady lenalidomide plus low-dose dexamethasone vs melphalan, prednisone, and thalidomide in patients with newly identified a number of myeloma. (page.tl)
  • In Groups B and C acceptable 'toxic' reactions occurred but were not simply related to melphalan levels. (ox.ac.uk)
  • Exposure to ionizing radiation can cause tissue reactions depending on the absorbed dose. (medscape.com)
  • Use with extreme caution in patients receiving MAO inhibitors within 14 days prior (may result in unpredictable, severe reactions-↓ initial dose of morphine to 25% of usual dose). (unboundmedicine.com)
  • Which of the following has the lowest incidence of extrapyramidal reactions, but has the highest incidence of agranulocytosis among antipsychotic agents? (kupdf.net)
  • Bortezomib was administered intravenously at doses of 1.3 mg/m2 twice weekly for two out of three weeks (21 day cycle). (drugcentral.org)
  • Melphalan Hydrochloride for Injection is administered intravenously. (nih.gov)
  • In reproductive studies in rats and rabbits, pamidronate doses equivalent to 0.6 to 8.3 times the highest human recommended dose resulted in maternal toxicity and embryo/fetal effects. (pfizermedicalinformation.com)
  • Using high performance liquid chromatography (HPLC) the concentrations of melphalan in the arterial and venous perfusate (during ILP) and in the systemic circulation (during and after ILP) were measured. (ox.ac.uk)
  • In all three groups the peak concentrations of melphalan were much higher in the perfusate than in the systemic circulation. (ox.ac.uk)
  • Mean (±SD) peak melphalan plasma concentrations in myeloma patients given intravenous melphalan at doses of 10 or 20 mg/m 2 were 1.2 ± 0.4 and 2.8 ± 1.9 mcg/mL, respectively. (nih.gov)
  • Dr. Martin presented the results from a dose-escalation study of SAR650948, 1 which was given in combination with a standard regimen of lenalidomide (Revlimid)/dexamethasone in 31 patients with relapsed/refractory disease. (ascopost.com)
  • The pharmacokinetics of SAR650984 and lenalidomide appear to be independent, he noted. (ascopost.com)
  • In randomised clinical trials, a subcutaneous dose of 230 µg/m 2 /day (4.0 to 8.4 µg/kg/day) was used. (medicines.org.uk)
  • In a proof of concept in vivo study, we also observed a therapeutic effect of adoptively transferred IL-15 expanded and IL-21 boosted NK cells in combination with image guided high precision radiation therapy using a luciferase-transduced RMS xenograft model. (frontiersin.org)
  • The clinical benefit rate was 65% overall and 67% with the maximum dose. (ascopost.com)
  • Chari's patient joined the phase 2 STORM trial (NCT02336815), which evaluated the combination of oral selinexor (Xpovio) plus low-dose dexamethasone in patients with refractory heavily pretreated MM. The patient saw significant clinical improvements, including in his renal function, enabling him to join other clinical trials. (onclive.com)
  • Some individuals may develop radiation nephropathy at a dose of radiation that has no clinical effect on others. (medscape.com)
  • The concepts, basic definitions, and different approaches to the clinical implementation of absorbed dose estimation are reviewed in this article. (snmjournals.org)
  • We describe melphalan pharmacokinetics in 26 patients treated by isolated limb perfusion (ILP). (ox.ac.uk)
  • The combination produced responses in 58% of patients overall, rising to 63% in patients receiving the highest dose, 10 mg/kg every 2 weeks. (ascopost.com)
  • Although the contribution of renal elimination to melphalan clearance appears to be low, one study noted an increase in the occurrence of severe leukopenia in patients with elevated BUN after 10 weeks of therapy. (nih.gov)
  • 20% of patients with an acute stone episode receive a 1-year cumulative medical imaging radiation dose of greater than 50 mSv. (medscape.com)
  • Renal deterioration, progression to renal failure, and dialysis have been reported in patients after the initial or a single dose of pamidronate disodium. (pfizermedicalinformation.com)
  • Higher infusion rates may be required and duration of action may be shortened in patients receiving long-term carbamazepine or phenytoin . (unboundmedicine.com)
  • Specialty and urgent care centers in high growth areas of the Valley and across the state serve the needs of patients and families in their own neighborhoods. (clinicaltrialsgps.com)
  • melphalan decreases effects of measles, mumps, rubella and varicella vaccine, live by pharmacodynamic antagonism. (medscape.com)
  • The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma. (ox.ac.uk)
  • In the last years, adoptive transfer of natural killer (NK) cells came into the focus of translational medicine, because of their high cytotoxic potential against transformed malignant cells. (frontiersin.org)
  • Melphalan is leukemogenic in humans. (nih.gov)
  • Melphalan produces chromosomal aberrations in vitro and in vivo and, therefore, should be considered potentially mutagenic in humans. (nih.gov)
  • Aside from these hydrolysis products, no other melphalan metabolites have been observed in humans. (nih.gov)
  • Controlled trials comparing intravenous (IV) to oral melphalan have shown more myelosuppression with the intravenous formulation. (nih.gov)
  • Arm 1: Oral melphalan 0.15 mg/kg/day x 7 followed by 0.05 mg/kg/day when WBC began to rise. (nih.gov)
  • One study has reported that on repeat dosing of 0.5 mg/kg every 6 weeks, the clearance of melphalan decreased from 8.1 mL/min/kg after the first course, to 5.5 mL/min/kg after the third course, but did not decrease appreciably after the third course. (nih.gov)
  • In practice, this term has been used to describe administered activity as well as absorbed dose. (snmjournals.org)
  • 2005) In children with acute lymphoblastic leukemia who received high-dose methotrexate, oxidative damage to proteins as well as other factors was related to toxic side effects. (pinestreetfoundation.org)
  • If a drug is repeatedly administered at dosing intervals equal to its elimination half-life, the number of doses required for the plasma concentration of the drug to reach the steady state is: A. 2 to 3 D. 8 to 9 B. 4 to 5 E. 10 or more C. 6 to 7 4. (kupdf.net)
  • The kinetics characteristic of elimination of ethanol and high doses of phenytoin and aspirin is known as A. Distribution B. Excretion C. First-pass effect D. First-order elimination E. Zero-order elimination 13. (kupdf.net)
  • 2003) As seen in this study, higher levels of natural antioxidants can help treatment outcomes. (pinestreetfoundation.org)
  • In summary, this two-phased feeder cell-free ex vivo culturing protocol combined efficient expansion and high cytolytic functionality of NK cells for treatment of radiation-resistant RMS. (frontiersin.org)
  • Consolidation therapy- Daratumumab 1,800 mg/hyaluronidase 30,000 units every 2 wk starting at Week 1 upon reinitiation of treatment following autologous stem cell transplant and continued until Week 8 (total of 4 doses). (drugguide.com)
  • if tolerated, ↑ dose to 27 mg/m 2 on Days 8, 9, 15, and 16 of a 28-day treatment cycle. (unboundmedicine.com)
  • Our Featured Research Page lists cancer prevention, treatment and quality of life studies enrolling people with or at high risk for hereditary cancers. (facingourrisk.org)
  • Long- and well-established cancer treatment experience in radiotherapy has provided ample evidence that absorbed dose may be used to predict biologic response ( 1 ). (snmjournals.org)
  • As has been recognized in radiotherapy and is beginning to be appreciated in radionuclide therapy, the rate at which the absorbed dose is delivered, the manner by which it is delivered (β-particles, α-particles, or Auger electrons), the radiobiologic characteristics of the tumor or normal organ, and the treatment history of the patient all affect response to a specific total absorbed dose ( 2 ). (snmjournals.org)
  • In experimental models, ultrastructural damage to the glomerular endothelium is observed 3 weeks after a 10-Gy (1000 rad) dose of local kidney irradiation, and neutrophil adherence to the endothelium occurs. (medscape.com)
  • Daily dosing with Neupogen should continue until the expected neutrophil nadir is passed and the neutrophil count has recovered to the normal range. (medicines.org.uk)
  • Our phase I study has allowed us to increase the dose of melphalan to 1.75 mg kg-1, but we found no pharmacokinetic advantage from divided dose administration. (ox.ac.uk)
  • Medication doses ought to be adjusted regularly as the kid grows to ensure the appropriate dosages are used. (llclinic.com)
  • Group A (n = 11) were treated with a bolus of melphalan (1.5 mg kg-1), and in a phase I study the dose was increased to 1.75 mg kg-1. (ox.ac.uk)
  • Creatinine clearance could be as low as 20 mL/min and bilirubin levels as high as 1.5 times the upper limit of normal. (drugcentral.org)
  • HMGB2 was detected at higher levels in human MSC as in comparison with human articular chondrocytes and its expression declined during chondrogenic differentiation of MSC. (cox-inhibitors.com)
  • Melphalan Hydrochloride for Injection is supplied as a sterile, nonpyrogenic, white to off-white lyophilized cake or powder. (nih.gov)
  • In the case of injury by radionuclide therapy, a radioisotope can injure the kidneys if its pharmacokinetics cause it to lodge in the kidney while it is still a radioemitter. (medscape.com)
  • Particular attention is placed on the marrow and kidney as dose-limiting organs. (snmjournals.org)
  • He was treated with liposomal doxorubicin 40 mg/m(2) every 4-6 weeks up to now with a total dose of 800 mg. (curehunter.com)
  • Arm 2: Intravenous melphalan 16 mg/m 2 q 2 weeks x 4 (over 6 weeks) followed by the same dose every 4 weeks. (nih.gov)
  • [ 6 ] By 6 to 10 weeks after the same dose, a wave of tubular epithelial cell deaths occurs. (medscape.com)
  • Our median follow-up is still less than 6 months, and only 2.7 months for the last patient dosed in the analysis. (ascopost.com)
  • A main challenge of NK cell therapy is that it requires a high amount of functional NK cells. (frontiersin.org)
  • Until the year 2000, the standard therapy for MM was melphalan- or doxorubicin-based regimens with corticosteroids. (biomedcentral.com)
  • The biologic effects of radionuclide therapy are mediated via a well-defined physical quantity, the absorbed dose, which is defined as the energy absorbed per unit mass of tissue. (snmjournals.org)
  • Unlike most other systemic treatments, the biologic effects of radionuclide therapy are mediated via a well-defined physical quantity, the absorbed dose, which is defined as the energy absorbed per unit mass of tissue. (snmjournals.org)
  • Until such methods are developed and validated, absorbed dose remains an important variable-but still one of several- likely to predict response in an individual patient. (snmjournals.org)
  • Approximately 30% of melphalan is (covalently) irreversibly bound to plasma proteins. (nih.gov)
  • Melphalan is eliminated from plasma primarily by chemical hydrolysis to monohydroxymelphalan and dihydroxymelphalan. (nih.gov)
  • The steady-state volume of distribution of melphalan is 0.5 L/kg. (nih.gov)
  • Finally, the potential role of radiobiologic modeling in helping to account for differences in dose rate and spatial distribution are reviewed. (snmjournals.org)
  • Our results demonstrated high potential of IL-15 for NK cell expansion, while IL-21 triggered NK cell maturation and functionality. (frontiersin.org)
  • Dr Goetzl says that while the very low doses wanted should not produce any side-results, he would never advise giving the drug to young women. (page.tl)
  • Cancer is a chronic disease that is responsible for the high death rate, globally. (mdpi.com)
  • The process by which the amount of orally-administered drug is reduced before it reaches the systemic circulation A. First-order kinetics D. Excretion B. First-pass effect E. Metabolism C. Pharmacokinetics 3. (kupdf.net)
  • The dose or concentration required to bring about 50% of a drug's maximal effect A. Potency D. Kd B. ED50 E. Therapeutic index C. Efficacy 6. (kupdf.net)
  • Current efforts to improve absorbed dose estimates by using more realistic anatomic models and implementing radiobiologic models that can be used to account for dose rate and uniformity are also reviewed. (snmjournals.org)
  • The intervention group had a 17% statistically significantly higher odds of uptake of additional HPV vaccinations than the usual care group (Adjusted Odds Ratio: 1.17, 95% CI: 1.01-1.36). (bvsalud.org)
  • Melphalan is an alkylating agent of the bischloroethylamine type. (nih.gov)
  • Melphalan is a bifunctional alkylating agent that is active against selected human neoplastic diseases. (nih.gov)